Tarıq MADKHALİ
(Department of Surgery, University of Wisconsin, Madison, USA)
Amal ALHEFDHİ
(Department of Surgery, University of Wisconsin, Madison, USA)
Herbert CHEN
(Department of Surgery, University of Wisconsin, Madison, USA)
Dawn ELFENBEİN
(Department of Surgery, University of Wisconsin, Madison, USA)
Yıl: 2016Cilt: 32Sayı: 1ISSN: 1300-0705 / 1308-8521Sayfa Aralığı: 58 - 66İngilizce

69 0
Primer hiperparatiroidizm
Primer hiperparatiroidizm paratiroid bezlerinin aşırı aktivasyonu sonucu paratiroid hormonunun aşırı salınması ile seyreden yaygın bir endokrin bozukluktur. Oluşan hiperkalsemi birçok semptoma neden olur. Tedavi edilmedi- ği takdirde primer hiperparatiroidi hastanın morbiditesini ve hatta mortaliteyi arttırabilir. Son yıllarda hastalığın ciddi kemik ve böbrek bulguları ile ortaya çıkan klasik tablosu artık çoğu hastanın rutin laboratuvar tetkikleri ile teşhis edilmesi yönünde değişmiştir. Ameliyat tek küratif tedavi olmasına rağmen, geçmiş yıllarda tanı ve primer hiperparatiroidi cerrahi tedavisinde ciddi ilerlemeler kaydedilmiştir. Bu derlemenin amacı, hastalığın özelliklerini, değerlendirme yöntemlerini ve tedavi seçeneklerini özetlemektir.
Fen > Tıp > Cerrahi
DergiDerlemeErişime Açık
  • Carneiro-Pla DM, Irvin GL, 3rd, Chen H. Consequences of parath- yroidectomy in patients with "mild" sporadic primary hyperpa- rathyroidism. Surgery 2007; 142: 795-799. [CrossRef]
  • Gopinath P, Mihai R. Hyperparathyroidism. Surgery 2011; 29: 451- 458. [CrossRef]
  • Cordellat IM. Hyperparathyroidism: primary or secondary disea- se? Rheumatol Clin 2012; 8: 287-291.
  • Conrad DN, Olson JE, Hartwig HM, Mack E, Chen H. A prospective evaluation of novel methods to intraoperatively distinguish pa- rathyroid tissue utilizing a parathyroid hormone assay. J Surg Res 2006; 133: 38-41. [CrossRef]
  • Westin G, Bjorklund P, Akerstrom G. Molecular genetics of parath- yroid disease. World J Surg 2009; 33: 2224-2233. [CrossRef]
  • Colaco SM, Si M, Reiff E, Clark OH. Hyperparathyroidism after radi- oactive iodine therapy. Am J Surg 2007; 194: 323-327. [CrossRef]
  • Eknoyan G. A history of the parathyroid glands. Am J Kidney Dis 1995; 26: 801-807. [CrossRef]
  • Organ CH, Jr. The history of parathyroid surgery, 1850-1996: the Excelsior Surgical Society 1998 Edward D Churchill Lecture. J Am Coll Surg 2000; 191: 284-299. [CrossRef]
  • Silverberg SJ, Lewiecki EM, Mosekilde L, Peacock M, Rubin MR. Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocri- nol Metab 2009; 94: 351-365. [CrossRef]
  • Bandeira F, Griz L, Caldas G, Bandeira C, Freese E. From mild to se- vere primary hyperparathyroidism: The Brazilian experience. Arq Bras Endocrinol Metabol 2006; 50: 657-663. [CrossRef]
  • Gopinath P, Sadler GP, Mihai R. Persistent symptomatic improve- ment in the majority of patients undergoing parathyroidectomy for primary hyperparathyroidism. Langenbecks Arch Surg 2010; 395: 941-946. [CrossRef]
  • Reiher AE, Mazeh H, Schaefer S, Gould J, Chen H, Sippel RS. Symptoms of gastroesophageal reflux disease improve after pa- rathyroidectomy. Surgery 2012; 152: 1232-1237. [CrossRef]
  • Bandeira F, Griz L, Chaves N, Carvalho NC, Borges LM, Lazaretti-Castro M, et al. Diagnosis and management of primary hyperparathyroidism- -a scientific statement from the Department of Bone Metabolism, the Brazilian Society for Endocrinology and Metabolism. Arq Bras Endoc- rinol Metabol 2013; 57: 406-424. [CrossRef]
  • Calvi LM, Sims NA, Hunzelman JL, Knight MC, Giovannetti A, Saxton JM, et al. Activated parathyroid hormone/parathyroid hormone-re- lated protein receptor in osteoblastic cells differentially affects corti- cal and trabecular bone. J Clin Invest 2001; 107: 277-286. [CrossRef]
  • Rubin E, Reisner HM. Essentials of RUBIN'S Pathology. 5th ed. Lip- pincott Williams & Wilkins, a Wolter Kluwer business 2009, Balti- more, MD, Philadelphia, PA 2009.p.552.
  • Joborn C, Hetta J, Johansson H, Rastad J, Agren H, Akerstrom G, et al. Psychiatric morbidity in primary hyperparathyroidism. World J Surg 1988; 12: 476-481. [CrossRef]
  • Gurrado A, Piccinni G, Lissidini G, Di Fronzo P, Vittore F, Testini M. Hypercalcaemic crisis due to primary hyperparathyroidism - a systematic literature review and case report. Endokrynol Pol 2012; 63: 494-502.
  • Jacobs TP, Bilezikian JP. Clinical review: Rare causes of hypercalce- mia. J Clin Endocrinol Metab 2005; 90: 6316-6322. [CrossRef]
  • Matikainen N. Hypercalcemia. Duodecim 2014; 130: 1404-1412.
  • Hinnie J. The management of primary hyperparathyroidism. Scott Med J 2013; 58: 251-253. [CrossRef]
  • Tordjman KM, Greenman Y, Osher E, Shenkerman G, Stern N. Cha- racterization of normocalcemic primary hyperparathyroidism. Am J Med 2004; 117: 861-863. [CrossRef]
  • Bollerslev J, Rolighed L, Mosekilde L. Mild primary hyperparath- yroidism and metabolism of vitamin D. IBMS BoneKEy 2011; 8: 342-351. [CrossRef]
  • Christensen SE, Nissen PH, Vestergaard P, Mosekilde L. Familial hypocalciuric hypercalcaemia: a review. Curr Opin Endocrinol Di- abetes Obes 2011; 18: 359-370. [CrossRef]
  • Gawrychowski J, Bula G. Imaging diagnostics for primary hyper- parathyroidism. Endokrynol Pol 2013; 64: 404-408. [CrossRef]
  • Dijkstra B, Healy C, Kelly LM, McDermott EW, Hill AD, O'Higgins N. Parathyroid localisation--current practice. J R Coll Surg Edinb 2002; 47: 599-607.
  • Kelly KJ, Chen H, Sippel RS. Primary hyperparathyroidism. Cancer Treat Res 2010; 153: 87-103. [CrossRef]
  • Johnson NA, Tublin ME, Ogilvie JB. Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyro- idism. AJR Am J Roentgenol 2007; 188: 1706-1715. [CrossRef]
  • Frasoldati A, Pesenti M, Toschi E, Azzarito C, Zini M, Valcavi R. Detection and diagnosis of parathyroid incidentalomas during thyroid sonography. J Clin Ultrasound 1999; 27: 492-8. [CrossRef]
  • Maser C, Donovan P, Santos F, Donabedian R, Rinder C, Scoutt L, et al. Sonographically guided fine needle aspiration with rapid parathyro- id hormone assay. Ann Surg Oncol 2006; 13: 1690-1695. [CrossRef]
  • Abdelghani R, Noureldine S, Abbas A, Moroz K, Kandil E. The diag- nostic value of parathyroid hormone washout after fine-needle aspiration of suspicious cervical lesions in patients with hyperpa- rathyroidism. Laryngoscope 2013; 123: 1310-1313. [CrossRef]
  • Bilezikian JP, Khan AA, Potts JT, Jr. Guidelines for the manage- ment of asymptomatic primary hyperparathyroidism: summary statement from the third international workshop. J Clin Endocri- nol Metab 2009; 94: 335-339. [CrossRef]
  • Zanocco K, Angelos P, Sturgeon C. Cost-effectiveness analysis of parathyroidectomy for asymptomatic primary hyperparathyroi- dism. Surgery 2006; 140: 874-882. [CrossRef]
  • Stavrakis AI, Ituarte PH, Ko CY, Yeh MW. Surgeon volume as a predictor of outcomes in inpatient and outpatient endocrine sur- gery. Surgery 2007; 142: 887-899. [CrossRef]
  • Murray SE, Pathak PR, Pontes DS, Schneider DF, Schaefer SC, Chen H, et al. Timing of symptom improvement after parathyroidectomy for pri- mary hyperparathyroidism. Surgery 2013; 154: 1463-1469. [CrossRef]
  • Nussbaum SR, Thompson AR, Hutcheson KA, Gaz RD, Wang CA. Intraoperative measurement of parathyroid hormone in the sur- gical management of hyperparathyroidism. Surgery 1988; 104: 1121-1127.
  • Norman J, Chheda H. Minimally invasive parathyroidectomy fa- cilitated by intraoperative nuclear mapping. Surgery 1997; 122: 998-1004. [CrossRef]
  • Barczynski M, Konturek A, Hubalewska-Dydejczyk A, Cichon S, Nowak W. Evaluation of Halle, Miami, Rome, and Vienna intraope- rative iPTH assay criteria in guiding minimally invasive parathyro- idectomy. Langenbecks Arch Surg 2009; 394: 843-849. [CrossRef]
  • Chen H, Mack E, Starling JR. Radioguided parathyroidectomy is equally effective for both adenomatous and hyperplastic glands. Ann Surg 2003; 238: 332-338. [CrossRef]
  • Ito F, Sippel R, Lederman J, Chen H. The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing. Ann Surg 2007; 245: 959-963. [CrossRef]
  • Schneider DF, Mazeh H, Sippel RS, Chen H. Is minimally invasive parathyroidectomy associated with greater recurrence compa- red to bilateral exploration? Analysis of more than 1,000 cases. Surgery 2012; 152: 1008-1015. [CrossRef]
  • Hughes DT, Miller BS, Park PB, Cohen MS, Doherty GM, Gauger PG. Factors in conversion from minimally invasive parathyroidec- tomy to bilateral parathyroid exploration for primary hyperpa- rathyroidism. Surgery 2013; 154: 1428-1435. [CrossRef]
  • Brasier AR, Nussbaum SR. Hungry bone syndrome: clinical and bi- ochemical predictors of its occurrence after parathyroid surgery. Am J Med 1988; 84: 654-660. [CrossRef]
  • Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year pros- pective study of primary hyperparathyroidism with or without pa- rathyroid surgery. N Engl J Med 1999; 341: 1249-1255. [CrossRef]
  • Selby P. Asymptomatic primary hyperparathyroidism - we have half the answers. Clin Endocrinol (Oxf) 2011; 75: 156-157. [CrossRef]
  • Oltmann SC, Maalouf NM, Holt S. Significance of elevated parath- yroid hormone after parathyroidectomy for primary hyperpa- rathyroidism. Endocr Pract 2011; 17(Suppl 1): 57-62.
  • Ning L, Sippel R, Schaefer S, Chen H. What is the clinical signi- ficance of an elevated parathyroid hormone level after curative surgery for primary hyperparathyroidism? Ann Surg 2009; 249: 469-472.
  • Schneider DF, Mazeh H, Chen H, Sippel RS. Predictors of recur- rence in primary hyperparathyroidism: an analysis of 1386 cases. Ann Surg 2014; 259: 563-568. [CrossRef]
  • O'Connell RL, Afors K, Thomas MH. Re-explorative parathyroid surgery for persistent and recurrent primary hyperparathyroi- dism. WJOES 2011; 3: 107-111. [CrossRef]
  • Thompson GB, Grant CS, Perrier ND, Harman R, Hodgson SF, Ils- trup D, et al. Reoperative parathyroid surgery in the era of sesta- mibi scanning and intraoperative parathyroid hormone monito- ring. Arch Surg 1999; 134: 699-705. [CrossRef]
  • Crowley RK, Gittoes NJ. When would I use medical therapies for the treatment of primary hyperparathyroidism? Clin Endocrinol (Oxf) 2013; 79: 770-773.
  • Pallan S, Khan A. Primary hyperparathyroidism: Update on pre- sentation, diagnosis, and management in primary care. Can Fam Physician 2011; 57: 184-189.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.